Management

show all hide all

Dave Becker

Executive Vice President & CFO, Acting President and CEO

David Becker has been our Executive Vice President, Chief Financial Officer since September 2008. Prior to joining us, Dave served as an independent consultant to various healthcare companies from March 2007 to June 2008, providing them with chief financial officer and/or chief executive officer services. In addition, Dave sat on the board of directors for several of these healthcare companies. From 2000 to 2007, Dave served as the Chief Financial Officer and Treasurer of Adams Respiratory Therapeutics, Inc. and served in various other capacities with Adams over that period including Chief Financial and Administrative Officer from October 2006 to February 2007, and interim Chief Operating Officer from May 2003 to April 2004. Prior to joining Adams, Mr. Becker was a Senior Manager in the merger and acquisitions practice of Ernst & Young LLP from November 1997 to September 2000. From January 1996 to November 1997, Mr. Becker served as Controller for the Salt Lake City-based start-up company RxAmerica LLC, a pharmacy benefit management and mail-service pharmacy operation. From 1991 to 1995, he served as a financial auditor with Ernst & Young LLP. Mr. Becker began his professional career in 1990 as an audit and tax accountant for the southern California-based accounting firm of Glenn M. Gelman & Associates. Mr. Becker earned a bachelor's degree in accounting in 1990 from the University of Southern Mississippi and is a certified public accountant and certified treasury professional.

Brad Cole

Senior Vice President, General Counsel and Secretary

Brad Cole has served as our Senior Vice President, General Counsel and Secretary since September 2008. He was the Associate General Counsel and Assistant Secretary at Adams Respiratory Therapeutics, Inc. from August 2004 to July 2008. From August 1999 to July 2004, he was with the law firm of Holland & Knight LLP, in the firms Tampa office and focused on corporate, securities and M&A matters. Brad began his career in the financial services industry and worked at several financial institutions from 1991 to 1994. Brad earned a bachelor's degree from the University of Miami in 1990;his Juris Doctorate, cum laude, from Thomas M. Cooley Law School in 1998; and a Masters of Laws in Securities and Financial Regulations, with honors, from the Georgetown University Law Center, in May 1999.

Timothy L. Miller

Senior Vice President, Commercial Operations

Timothy L. Miller has served as our Senior Vice President, Sales Operations & Administration since September 2008. Prior to joining us, Tim served as the Vice President Sales Operations & Training at Adams Respiratory Therapeutics, Inc. from September 2004 to July 2008. From 1986 to 2004, he held various positions at Aventis Pharmaceuticals and its legacy companies, including Hoechst Marion Roussel, Marion Merrell Dow, and Marion Labs. Tim's positions at Aventis and its legacy companies included Financial Analyst, Manager Commercial Financial Services, Regional Business Manager, Senior Manager Sales Information & Incentives, and Director Sales Operations. Tim graduated from Emporia State University in 1978 earning a Bachelor of Science in Business, with a concentration in accounting. Tim received his Master in Business Administration in 1983, with a concentration in finance, from Rockhurst University, a Jesuit institution in Kansas City.

Donald J. Treacy, Ph.D

Senior Vice President, Pharmaceutical Development and Quality

Donald J. Treacy, Ph.D. has served as our vice president, analytical sciences since January 2004. Dr. Treacy joined us as director, analytical research and development in March 2000. Dr. Treacy has 13 years of industry experience including 12 years in drug development and novel drug delivery systems.

From 1993 to 2000, Dr. Treacy was employed at Shire Laboratories, Inc./Pharmavene. While at Shire Laboratories, he held management positions with increasing responsibilities in analytical method development, validation, clinical trial material release and NDA stability. Prior to that, Dr. Treacy performed analytical method development and photodegradation research at the National Cancer Institute. Dr. Treacy has a bachelor's degree from Roanoke College and received a Ph.D. in analytical chemistry from the University of Maryland.